XML 47 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Share-Based Compensation Expense
The following table summarizes non-cash share-based compensation expense (in thousands):
December 31,
202020192018
Share-based compensation expense as a component of:
Research and development expenses$13,497 $9,641 $8,352 
General and administrative expenses17,230 14,874 12,494 
$30,727 $24,515 $20,846 
Schedule of Stock Option Plan Activity
Following is a summary of our stock option plan activity and related information:
 
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term in
Years
Aggregate
Intrinsic
Value
(In  thousands)
Balance at January 1, 20181,876,332 $53.17 5.77$157,340 
Granted228,362 $162.00 
Exercised(358,162)$55.24 
Forfeited(10,228)$114.53 
Balance at December 31, 20181,736,304 $66.71 5.47125,858 
Exercisable at December 31, 20181,313,374 $47.03 4.56117,314 
Options vested and expected to vest as of December 31, 20181,736,304 $66.71 5.47$125,858 
Granted338,617 $116.69 
Exercised(112,011)$23.65 
Forfeited(6,531)$139.37 
Balance at December 31, 20191,956,379 $77.54 5.4572,002 
Exercisable at December 31, 20191,454,726 $61.82 4.4270,345 
Options vested and expected to vest as of December 31, 20191,956,379 $77.54 5.45$72,002 
Granted806,300 $92.93 
Exercised(156,845)$21.26 
Forfeited(44,012)$91.30 
Balance at December 31, 20202,561,822 $85.59 6.0959,033 
Exercisable at December 31, 20201,611,830 $76.05 4.5453,286 
Options vested and expected to vest as of December 31, 20202,561,822 $85.59 6.09$59,033 
Schedule of Stock Option Plan Activity by Exercise Price Range
Following is a further breakdown of the options outstanding as of December 31, 2020:
 
Range of exercise prices
Options
outstanding
Weighted
average
remaining  life
in years
Weighted average
exercise price
Options
exercisable
Weighted average
exercise price
$10.05-$14.47
284,184 0.86$13.08 270,184 $13.00 
$21.92-$56.26
344,629 2.88$35.34 344,629 $35.34 
$63.58-$74.42
307,356 5.20$71.96 220,650 $73.41 
$82.90-$95.35
185,033 6.23$86.22 140,400 $86.32 
$95.68305,106 9.12$95.68 63,059 $95.68 
$97.924,976 5.02$97.92 4,976 $97.92 
$98.20270,850 9.26$98.20 — $98.20 
$100.02-$113.76
257,914 6.69$104.12 220,092 $103.96 
$117.5819,744 9.44$117.58 — $117.58 
$117.97-$195.91
582,030 7.56$137.18 347,840 $141.38 
2,561,822 6.09$85.59 1,611,830 $76.05 
Schedule of Stock Option Weighted-Average Assumptions
The assumptions used for the specified reporting periods and the resulting estimates of weighted-average grant date fair value per share of options granted:

 Year Ended December 31,
 202020192018
Risk-free interest rate
0.2%-1.4%
1.4%-2.6%
2.7%-3.0%
Expected volatility
47%-71%
40%-49%
33%-36%
Expected term
4.7 to 5.1 years
4.6 to 5.9 years
5.1 to 5.8 years
Schedule of Restricted Stock Activity
The following is a summary of our restricted stock activity and related information: 
Shares
Weighted-Average
Grant Date Fair
Value
Outstanding at January 1, 2018133,294 $91.60 
Granted62,133 $169.92 
Vested(61,989)$86.19 
Forfeited(1,165)$125.16 
Outstanding at December 31, 2018132,273 $130.63 
Granted118,498 $115.90 
Vested(102,846)$121.55 
Forfeited(666)$134.36 
Outstanding at December 31, 2019147,259 $125.11 
Granted111,306 $89.73 
Vested(52,363)$121.69 
Forfeited— $— 
Outstanding at December 31, 2020206,202 $106.88